Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study. - Hong DS; Bauer TM; Lee JJ; Dowlati A; Brose MS; Farago AF; Taylor M; Shaw AT; Montez S; Meric-Bernstam F; Smith S; Tuch BB; et al. (Annals of oncology : official journal of the European Society for Medical Oncology, 2019)